Table 1.
Characteristics and Outcomes of Women with Controlled Hypertension and Stable Health Insurance in the Women's Interagency HIV Study, 2005–2014
| Group A: HIV-infected, health insurance n = 842 | Group B: HIV-infected, health insurance or ADAP n = 842 | Group C: HIV-uninfected n = 842 | |
|---|---|---|---|
| Baseline | |||
| Age in years, median (IQR) | 47.7 (42.4–52.4) | 47.6 (42.0–52.3) | 47.3 (41.6–52.8) |
| Race, n (%) | |||
| African American | 575 (68.3) | 587 (66.0) | 193 (71.0) |
| White | 145 (17.2) | 162 (18.2) | 38 (14.0) |
| Other | 122 (14.5) | 141 (15.8) | 41 (15.1) |
| Site, n (%) | |||
| Bronx | 181 (21.5) | 181 (20.3) | 81 (29.8) |
| Brooklyn | 164 (19.5) | 168 (18.9) | 44 (16.2) |
| Washington, D.C. | 126 (15.0) | 129 (14.5) | 39 (14.3) |
| Los Angeles | 95 (11.3) | 127 (14.3) | 32 (11.8) |
| San Francisco | 138 (16.4) | 140 (15.7) | 47 (17.3) |
| Chicago | 138 (13.4) | 145 (16.6) | 29 (10.7) |
| CD4 count, cells/mm3, median (IQR) | 497 (308–715) | 495 (307–714) | N/A |
| HIV viral load, copies/mL, median (IQR) | 40 (40–1,700) | 40 (40–1,300) | N/A |
| Receiving ART, n (%) | 638 (75.8) | 684 (76.9) | N/A |
| Prior AIDS, n (%) | 369 (43.8) | 381 (42.8) | N/A |
| Systolic blood pressure, mmHg, median (IQR) | 119 (111–129) | 119 (111–129) | 124 (114–131.5) |
| Diastolic blood pressure, mmHg, median (IQR) | 75 (69–81) | 74 (68–81) | 75 (69–82) |
| BMI, median (IQR) | 28.8 (24.2–34.7) | 29.1 (24.5–34.8) | 33.3 (28.0–39.3) |
| Annual household income, n (%) | |||
| <$6,000 | 117 (13.9) | 131 (14.7) | 58 (21.3) |
| $6,001–$12,000 | 340 (40.4) | 349 (39.2) | 83 (30.5) |
| $12,001–$18,000 | 118 (14.0) | 130 (14.6) | 37 (13.6) |
| >$18,000 | 267 (31.7) | 280 (31.5) | 94 (34.6) |
| Education, n (%)a | |||
| Less than high school | 318 (37.8) | 343 (38.6) | 98 (36.2) |
| High school | 253 (30.1) | 266 (29.9) | 93 (34.3) |
| More than high school | 270 (32.1) | 280 (31.5) | 80 (29.5) |
| Health insurance type, n (%) | |||
| Medicaid | 647 (76.8) | 632 (71.0) | 183 (67.3) |
| Private | 155 (18.4) | 149 (16.7) | 63 (23.2) |
| Medicare | 25 (3.0) | 25 (2.8) | 11 (4.0) |
| Other public | 13 (1.5) | 12 (1.3) | 10 (3.7) |
| Not categorizable | 2 (0.2) | 2 (0.2) | 5 (1.8) |
| ADAP only | 0 (0.0) | 70 (7.9) | 0 (0.0) |
| ADAP, n (%) | 111 (13.2) | 174 (19.6) | N/A |
| Follow-up | |||
| Visits, n; median (IQR) | 5,030; 4 (2–8) | 5,362; 4 (2–8) | 1,498; 4 (2–7) |
| Systolic blood pressure, mmHg, median (IQR) | 119 (110–131) | 119 (110–131) | 122 (112–133) |
| Diastolic blood pressure, mmHg, median (IQR) | 73 (68–80) | 73 (68–80) | 75 (69–81) |
| Health insurance interruption, n (%)b | 73 (8.7) | 58 (6.5) | 40 (14.7) |
| Person-years, n | 2125.5 | 2270.3 | 620.4 |
| Median (IQR) | 1.6 (0.8–3.6) | 1.6 (0.8–3.6) | 1.5 (0.6–3.1) |
| Before interruption (%) | 1949.1 (91.7) | 2129.6 (93.8) | 528.1 (85.1) |
| After interruption (%) | 176.4 (8.3) | 140.7 (6.2) | 92.3 (14.9) |
| Outcome, n (%) | |||
| Censored due to missed visits or death | 89 (10.6) | 101 (11.3) | 22 (8.1) |
| Active at end of follow-up | 184 (21.9) | 189 (21.2) | 45 (16.5) |
| Loss of hypertension control | 569 (67.6) | 600 (67.4) | 205 (75.4) |
| Before interruption (%) | 523 (91.9) | 561 (93.5) | 176 (85.9) |
| After interruption (%) | 46 (8.1) | 39 (6.5) | 29 (14.1) |
a
Data missing on one woman in each HIV-infected group and on one HIV-uninfected woman.
b
Defined as absence of health insurance and absence of ADAP for “HIV-infected, health insurance, or ADAP” group.
ADAP, AIDS Drug Assistance Program; ART, antiretroviral therapy; BMI, body mass index; IQR, interquartile range; N/A, not applicable; WIHS, Women's Interagency HIV Study.